Dirk Hempel

415 total citations
35 papers, 186 citations indexed

About

Dirk Hempel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dirk Hempel has authored 35 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Dirk Hempel's work include Gastric Cancer Management and Outcomes (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Dirk Hempel is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Dirk Hempel collaborates with scholars based in Germany, Austria and Spain. Dirk Hempel's co-authors include Andreas Gäumann, Valeria Milani, Patrick Philipp, Philipp J. Jost, Stefanie Jilg, Torsten Haferlach, Catharina Müller‐Thomas, Christian Peschel, Katharina S. Götze and Burkhard Schmidt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Dirk Hempel

28 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Hempel Germany 8 72 61 55 43 29 35 186
Alain Mina United States 9 70 1.0× 49 0.8× 69 1.3× 47 1.1× 40 1.4× 31 201
Shanbo Cao China 9 68 0.9× 77 1.3× 74 1.3× 40 0.9× 61 2.1× 46 219
Shyam Aggarwal India 9 118 1.6× 41 0.7× 37 0.7× 23 0.5× 41 1.4× 38 208
Kota Yoshifuji Japan 6 53 0.7× 31 0.5× 111 2.0× 57 1.3× 34 1.2× 28 208
Dong Won Baek South Korea 10 126 1.8× 37 0.6× 36 0.7× 57 1.3× 29 1.0× 52 285
Wei-Shou Hwang Taiwan 7 118 1.6× 48 0.8× 46 0.8× 20 0.5× 26 0.9× 11 410
Paola Minetto Italy 10 97 1.3× 18 0.3× 72 1.3× 85 2.0× 19 0.7× 39 254
Maliha Nusrat United States 7 138 1.9× 30 0.5× 56 1.0× 28 0.7× 40 1.4× 20 213
Oraianthi Fiste Greece 11 154 2.1× 84 1.4× 43 0.8× 18 0.4× 62 2.1× 40 270
Justin Shaya United States 8 80 1.1× 92 1.5× 39 0.7× 11 0.3× 47 1.6× 18 179

Countries citing papers authored by Dirk Hempel

Since Specialization
Citations

This map shows the geographic impact of Dirk Hempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hempel more than expected).

Fields of papers citing papers by Dirk Hempel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Hempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hempel. The network helps show where Dirk Hempel may publish in the future.

Co-authorship network of co-authors of Dirk Hempel

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Hempel. A scholar is included among the top collaborators of Dirk Hempel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Hempel. Dirk Hempel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paradies, Kerstin, Timo Schinköthe, Renate Haidinger, et al.. (2024). Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative. European Journal of Oncology Nursing. 74. 102770–102770.
2.
Hempel, Dirk, et al.. (2024). MM-107 Teclistamab Success in CAR-T Refractory Multiple Myeloma: A Case Presentation. Clinical Lymphoma Myeloma & Leukemia. 24. S536–S536.
3.
Aigner, Michael, et al.. (2023). Responses of patients with cancer to mRNA vaccines depend on the time interval between vaccination and last treatment. Journal for ImmunoTherapy of Cancer. 11(9). e007387–e007387. 6 indexed citations
4.
Grünwald, Viktor, Daniel Pink, Gerlinde Egerer, et al.. (2022). 1496P Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study. Annals of Oncology. 33. S1231–S1231. 1 indexed citations
5.
6.
Gäumann, Andreas, Sebastian Robert, Josef Scheiber, et al.. (2021). Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib. memo - Magazine of European Medical Oncology. 14(4). 386–391.
7.
Hempel, Dirk, Florian Ebner, Arun Garg, et al.. (2020). Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients. Scientific Reports. 10(1). 10459–10459. 25 indexed citations
8.
9.
Eberl, Thomas, Andreas Gäumann, Dirk Hempel, et al.. (2020). Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification. Zeitschrift für Gastroenterologie. 3 indexed citations
10.
Al‐Batran, Salah‐Eddin, Christoph Maintz, Thorsten Oliver Goetze, et al.. (2020). Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. The Oncologist. 25(8). e1181–e1187. 15 indexed citations
11.
Jilg, Stefanie, Lars Buschhorn, Veronika Dill, et al.. (2019). Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose. Experimental Hematology and Oncology. 8(1). 9–9. 32 indexed citations
12.
Robert, Sebastian, et al.. (2019). Modeling of Medical Treatment Processes for an Interactive Assistance Based on the Translation of UML Activities into PROforma. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 972–976. 1 indexed citations
13.
Müller‐Thomas, Catharina, Niroshan Nadarajah, Rainer Burgkart, et al.. (2018). Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile. Oncotarget. 9(25). 17270–17281. 17 indexed citations
14.
Hempel, Dirk & Yvonne Fischer. (2016). Oncoguide system - A computerized self-learning interactive assistance system for the diagnosis and treatment of CML / MPN and MDS. Annals of Oncology. 27. vi11–vi11. 1 indexed citations
15.
Philipp, Patrick, Yvonne Fischer, Dirk Hempel, & Jürgen Beyerer. (2015). Modeling of clinical practice guidelines for interactive assistance in diagnostic processes. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 2 indexed citations
16.
Hempel, Dirk, et al.. (2015). Psychological, physical, and social situation of patients with Hodgkin lymphoma undergoing radical chemoradiotherapy. Progress in Health Sciences. 5(2). 69–76. 1 indexed citations
17.
Fischer, Yvonne, et al.. (2015). Framework for an Interactive Assistance in Diagnostic Processes Based on the Translation of UML Activities into Petri Nets. Fraunhofer-Publica (Fraunhofer-Gesellschaft). 732–737. 2 indexed citations
18.
Ehrl, Denis, et al.. (2014). Importance of liver resection in case of hepatic breast cancer metastases.. PubMed. 60(128). 2026–33. 8 indexed citations
19.
Hempel, Dirk, et al.. (2009). "Denn wovon lebt der Mensch?" : Literatur und Wirtschaft. Peter Lang eBooks.
20.
Hempel, Dirk, et al.. (2002). Das Echolot : ein kollektives Tagebuch. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Mina Breakdown of academic impact, for papers by Shanbo Cao Breakdown of academic impact, for papers by Shyam Aggarwal Breakdown of academic impact, for papers by Kota Yoshifuji Breakdown of academic impact, for papers by Dong Won Baek Breakdown of academic impact, for papers by Wei-Shou Hwang Breakdown of academic impact, for papers by Paola Minetto Breakdown of academic impact, for papers by Maliha Nusrat Breakdown of academic impact, for papers by Oraianthi Fiste Breakdown of academic impact, for papers by Justin Shaya
Rankless by CCL
2026